New Results
Programmable Drug Control of Receptor Valency Modulates the Potency of Cell Therapeutics
Paul B. Finn, Michael Chavez, Xinyi Chen, Haifeng Wang, Draven A. Rane, Jitendra Gurjar, View ORCID ProfileLei S. Qi
doi: https://doi.org/10.1101/2023.01.04.522664
Paul B. Finn
1Department of Bioengineering, Stanford University, Stanford, CA, USA
2Sarafan ChEM-H, Stanford University, Stanford, CA, USA
Michael Chavez
1Department of Bioengineering, Stanford University, Stanford, CA, USA
Xinyi Chen
1Department of Bioengineering, Stanford University, Stanford, CA, USA
Haifeng Wang
1Department of Bioengineering, Stanford University, Stanford, CA, USA
Draven A. Rane
1Department of Bioengineering, Stanford University, Stanford, CA, USA
Jitendra Gurjar
2Sarafan ChEM-H, Stanford University, Stanford, CA, USA
4Novartis Institutes for BioMedical Research, San Diego, CA, USA
Lei S. Qi
1Department of Bioengineering, Stanford University, Stanford, CA, USA
2Sarafan ChEM-H, Stanford University, Stanford, CA, USA
3Chan Zuckerberg Biohub, San Francisco, CA, USA

Article usage
Posted January 04, 2023.
Programmable Drug Control of Receptor Valency Modulates the Potency of Cell Therapeutics
Paul B. Finn, Michael Chavez, Xinyi Chen, Haifeng Wang, Draven A. Rane, Jitendra Gurjar, Lei S. Qi
bioRxiv 2023.01.04.522664; doi: https://doi.org/10.1101/2023.01.04.522664
Subject Area
Subject Areas
- Biochemistry (9159)
- Bioengineering (6797)
- Bioinformatics (24054)
- Biophysics (12149)
- Cancer Biology (9564)
- Cell Biology (13820)
- Clinical Trials (138)
- Developmental Biology (7654)
- Ecology (11733)
- Epidemiology (2066)
- Evolutionary Biology (15536)
- Genetics (10665)
- Genomics (14353)
- Immunology (9504)
- Microbiology (22887)
- Molecular Biology (9120)
- Neuroscience (49094)
- Paleontology (357)
- Pathology (1487)
- Pharmacology and Toxicology (2579)
- Physiology (3851)
- Plant Biology (8349)
- Synthetic Biology (2300)
- Systems Biology (6204)
- Zoology (1302)